Canada: IP Litigation In The Cannabis Industry: A Review Of The Limited Authority In Canada Thus Far

Last Updated: October 1 2018
Article by Joshua W. Spicer

As the day draws near to the legalization of recreational cannabis in Canada, so too does the birth of a new and significant industry. Arguably, Canada has been headed in this direction for close to 20 years. Some would point to the 2000 decision of R v Parker1—in which the Ontario Court of Appeal declared the marijuana prohibition in the Controlled Drugs and Substances Act to be invalid—as the first in a long line of dominos to fall in the path to legalization.

Whereas to date the majority of cannabis related case law has been in the area of criminal law, once the competitive market officially opens, participants should expect that disputes will arise for adjudication in the civil context. Intellectual property rights will play an important role in shaping the competitive landscape as the industry matures and competitors seek to establish their places in the market.

Litigation is inevitable.

Indeed, United Cannabis Corporation recently launched the first "cannabis" patent infringement action against Pure Hemp Collective Inc in the US,2 relating to a patent for liquid formulations of highly enriched extracts of plant cannabinoids. The case was commenced in the US District Court for the District of Colorado on July 30, 2018, and is sure to be closely followed as it progresses. Canada however, has already seen a handful of cannabis related intellectual property disputes decided by the courts and quasi-judicial bodies. In this paper, we discuss the small number of reported decisions to date and draw some inferences as to what future litigation may hold for the industry.

Patent Infringement

Patents represent a potentially fertile area for cannabis related litigation. Although plants themselves are not patentable3, many other related technologies are. As reported here,4 patent protection is available for genetically modified cannabis plant cells as well as novel isolated genes that produce cannabis active agents. Patents are also available for: 1) novel or modified active ingredients extracted from the cannabis plant or chemically synthesized; 2) novel formulations comprising cannabis active agents such as patches and gels or new combinations of ingredients; 3) new uses of the cannabis or cannabis extracts for example new indications that were not previously treated with cannabis products; 4) new methods of extracting cannabis active ingredients from the plants; and 5) new devices for delivery of the cannabis products, such as vaporisers and patches.5

So far, litigation in the area has been scarce with only one reported decision from proceedings commenced in 2008: Delp v Fresh Headies Internet Sales Ltd.6 Fresh Headies involved a patent for a method and apparatus for extracting resins from plants. The plaintiff sued for infringement, and following examinations for discovery faced a motion for summary judgment. The defendant moved on the basis that the claims included apparatus that would not work and therefore lacked the required utility for a patent. The Court disagreed and dismissed the motion. The proceeding was ultimately settled and discontinued in 2014.

If Fresh Headies is any indication, litigation involving cannabis related patents should be expected to proceed like cases involving any other technology. One nuance that cannabis patents may present, however, could relate to the availability of prior art that defendants are able to locate to challenge validity. Given the illicit status of cannabis historically, its development and that of related technologies has been largely underground. As a result, the usual sources for prior art, such as patent databases and literature periodicals, may prove less useful than in other areas of technology where advances in the art are routinely publicized. Companies holding patents with broad coverage over seminal cannabis technologies may well find themselves in a position to monopolize important aspects of the market, while facing weaker challenges to the validity of their patent rights than litigants in other industries.

Trademark Litigation

Trademark rights are so far the most litigated intellectual property rights related to cannabis in Canada. This is noteworthy because, as discussed here,7 many cannabis companies have filed trademark applications for words and symbols that may now be contrary to the Cannabis Act's branding rules. However, as also previously discussed, the Canadian Intellectual Property Office is not examining trademark applications for compliance with the Cannabis Act.8 The issue is certain to provoke further litigation and to subject applications to challenge in opposition proceedings. The trademarks considered in the cases in Canada to date were not subject to the limitations imposed by the Cannabis Act. It remains an open question as to how trademarks implicated by the branding rules will be handled in future litigation.

The earliest reported decision, from 2002, may provide some insight. In Cadbury Confectionary Canada Inc v Valliant-Saunders,9 the Trademarks Opposition Board had before it an opposition to an application for CANNABIS CRUNCH. Apart from grounds of confusion with the opponent's CRISPY CRUNCH trademark, the opponent also argued the application was non-compliant with section 30(i) of the Trademarks Act. The application covered wares including "chocolate bars comprising mainly of cannabis seeds". The opponent alleged that the applicant could not be satisfied he was entitled to use the mark in Canada because doing so would be illegal.

The Board disagreed. The opponent had conceded legislation indicating that the sale and use of non-viable cannabis seeds is legal in Canada, and allowing those with THC content of less than 10 ppm to be used in food products. The Board therefore found the applicant could make legal use of certain types of cannabis seeds in its proposed chocolate bar and rejected the ground of opposition.

The cannabis opposition proceedings since Cadbury have not addressed the illegality issue under section 30(i), or otherwise considered the illicit nature of the related wares in the applications in issue. The fact that the subject matter of the applications in issue related to cannabis had little if any effect on the arguments made or the judgments rendered.

In Avalon Sunsplash Ltd v Friendly Stranger Corp,10 an appeal to the Federal Court, the issue was whether the disputed applications lacked distinctiveness in view of the opponent's use of the CANNABIS CULTURE trademark. Allowing the appeal in part, the Court held the FRIENDLY STRANGER CANNABIS CULTURE SHOP trademark was sufficiently distinctive, and upheld the Board's rejection of the CANNABIS CULTURE application in view of the opponent's identical mark.

Remo Cannabrands Inc v Advanced Nutrients Ltd11 involved an opposition to the URBAN GROWER trademark in association with instructional videos. The opponent alleged it owned the mark and conceived of it for use with a video series to assist people with growing marijuana. The Board agreed, finding the applicant was not entitled to use mark, had been licensed and its use of the mark enured to the opponent.

Most recently, in Kesselman and International Herbs Medical Marijuana Ltd, Re,12 the Board dismissed objections to the ZENABIS trademark for goods and services related to marijuana. The Board held the opponent's use of its ZEN trademark since 2000 in association with cigarette papers and tobacco smoking accessories was insufficient to reject the application on the basis of confusion and lack of distinctiveness.

Outside of opposition proceedings, there is one reported trademark infringement case: Trans-High Corp v Hightimes Smokeshop and Gifts Inc.13 Relying on the Federal Court of Appeal's decision in BBM Canada v Research in Motion Ltd,14 the applicant proceeded by way of application—instead of action—seeking damages for trademark infringement, passing off and depreciation of goodwill. The applicant was the owner of the HIGH TIMES trademark for magazines and related merchandise, which it sold in retail stores in Canada and on its website. The respondent operated a retail store in Niagara Falls offering cannabis paraphernalia under the name "Hightimes Smokeshop and Gifts Inc." using a font similar to that used on the applicant's magazines.

Applying the "casual consumer somewhat in a hurry" test and section 6(5) of the Trademarks Act, the Court held that there was a likelihood of confusion between the applicant's use of the HIGH TIMES mark for its magazines and related wares and the respondent's use of the mark on its storefront. It also found the respondent had caused damage to the applicant's reputation and business, but held the evidence was insufficient to establish depreciation of goodwill. The Court awarded damages and costs in amounts of $25,000 and $30,000, respectively.

CIRA Domain Name Disputes

The Canadian Internet Registration Authority has so far adjudicated two separate domain name disputes involving cannabis providers. Unlike the post-Cadbury trademark opposition proceedings, illegality of the cannabis related subject matter played a role in both cases.

In the first, Prairie Plant Systems Inc v Lawson,15 the complainant sought to have the domain name transferred to it on the basis the name was confusingly similar to its CANNIMED trademark. The complainant registered the mark in 2004 and had since used it in the licenced supply of medical marijuana. The registrant was an unlicensed supplier and registered the disputed domain name 2010. Applying the applicable "first impression and imperfect recollection" test under the CIRA Dispute Resolution Policy, the Authority found the disputed domain name and CANNIMED trademark were confusingly similar. In finding the registrant had no legitimate interest in the domain name, inter alia, the Authority referred to the fact that the registrant was selling medical marijuana without the required licence. The Authority ordered that the registration for the domain name be transferred to the complainant.

Earlier this year, the illegal nature of the registrant's activities played more heavily in CIRA's analysis in Delta9 Bio-Tech and Delta Nine, Re.16 The registrant operated an illegal marijuana dispensary under the name Delta Nine and registered the dispute domain name in 2016. The complainant, who had registered its domain name in 2012 and had unregistered rights in three DELTA 9 trademarks dating to 2013 and pending trademark applications, sought to have the registration for the disputed domain name transferred to it.

The Authority found the disputed domain name confusingly similar with the DELTA 9 marks. The illegality of the registrant's business was an important factor in the Authority's consideration of both whether the applicant had a legitimate interest in the registration and whether it had acted in bad faith. In respect of the former, the Authority held: "It is illegal and unprincipled in every respect and cannot possibly justify the registration of the domain name."17 For the latter:

...the intention of the Registrant was to register the domain name because it reflected the Complainant's established trademark in the medical cannabis business and to use it for an illegal purpose to further its own interests and for a purpose that would benefit the Registrant financially by taking away some of the Complainant's potential business. That conduct constitutes bad faith registration on any test.18

Post legalization, the availability of arguments based on illegality will surely be muted to some extent depending on the regimes implemented in the provinces for the sale of cannabis. Still, on the basis of this authority, the legality of a registrant's operations should remain an important factor in the consideration of the legitimacy of its interest in a disputed domain name and whether its registration was made in bad faith.

Plant Breeders' Rights and Trade Secrets

So far there are no reported decisions related to these intellectual property rights in cannabis or related products. Both areas, however, represent valuable tools in the field and it should be expected that disputes will arise. As discussed here,19 novel cannabis varieties may be protected under the Plant Breeders' Rights Act, giving a cannabis breeder exclusive rights to the propagating material of their variety for a period of 20 years. A trade secret is, in essence, valuable information to a business that the business keeps and maintains as secret, and are of infinite duration so long as the secret is kept. The most famous is probably the Coke formula, which has been maintained as a trade secret for more than 100 years. Traditionally, plant breeders' rights are rarely asserted in litigation. On the other hand, trade secrets cases arise routinely and often in the context of departing employees. Given the pace of growth in the cannabis industry, companies would be well advised to consider their procedures for maintaining these assets as employees inevitably continue to move around. Also, given the protection afforded by plant breeders' rights and the potential commercial value of a popular strain, we could well see cannabis driving an increase in related litigation.

Looking Ahead

What can be drawn from the small sample of cases so far?

One observation is that intellectual property disputes related to the emerging cannabis industry will be adjudicated much like those in other industries. While limitations on packaging and the legality of some activities may be uncertain today, overall, future cases ought to be decided for the most part based on established legal principles. These principles will help to ensure that as the industry matures the value of IP rights will grow in the hands of companies investing in the innovation of new technologies and in strengthening their brands. Industry players will benefit who pursue a strategy of protecting and enforcing their rights and also of being mindful of rights held by their competitors.


1 (2000), 49 OR (3d) 481 (ON CA)

2 Case 1:18-cv-01922, filed 07/30/18 (USDC Colorado)

3 As discussed below, they may, however, be proper subject matter for protection under the Plant Breeders' Rights Act.

4 IP Protection for Cannabis in Canada, June 28, 2018, Micheline Gravelle and Herman Cheung: [IP Protection]; see also Growing Your Cannabis IP Rights, Life Sciences Expert Guide 2018, Micheline Gravelle:

5 Ibid

6 (2011), 97 CPR (4th) 139 (FC) [Fresh Headies]

7 Branding and Cannabis: A "Blunt" List of Ten Things Companies Must Know about Canadian Cannabis Branding Limitations, August 15, 2018, Cynthia Rowden and Tamara Céline Winegust:

8 Ibid

9 (2002), 22 CPR (4th) 388 (TMOB) [Cadbury]

10 (2010), 82 CPR (4th) 10 (FC)

11 (2017), 155 CPR (4th) 74 (TMOB)

12 (2018), 155 CPR (4th) 151 (TMOB)

13 (2013), 117 CPR (4th) 254 (FC) [Trans-High]

14 2011 FCA 151

15 2013 CarswellNat 3854 (CIRA)

16 2018 CarswellNat 2743 (CIRA)

17 Ibid at para 77

18 Ibid at para 93

19 IP Protection, note 3 supra

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Joshua W. Spicer
In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions